Regeneron Pharmaceuticals, Inc. (REGN) vs Vertex Pharmaceuticals Incorporated (VRTX)
Regeneron Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $81.3B — 1.6× the size. Regeneron Pharmaceuticals, Inc. trades at the lower P/E: 18.8× against 30.4×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.2% against 9.29%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 27.9%) and the higher return on invested capital (24.1% vs 9.34%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 13 and Regeneron Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | REGN | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 84.86% | 86.00% | 65.16% |
| Operating margin | 24.74% | 37.95% | 0.00% |
| Net margin | 27.86% | 35.00% | 0.00% |
| Free cash flow margin | 23.01% | 30.16% | 0.00% |
| Return on equity | 14.04% | 23.54% | (57.72%) |
| Return on assets | 10.83% | 17.12% | (49.22%) |
| Return on invested capital | 9.34% | 24.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack